gip vs glp-1 The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism New strategies for the treatment
Description
General best practice: Monthly for the first 3 months (especially with GLP-1s to monitor GI side effects and adjust dosing), then every 2-3 months once stable
PMID: 41122341
de la Cuesta-Zuluaga et al., 2017
At mctlaw she litigates cases for clients with defective hip replacements and defective drug and pharmaceutical lawsuits
Do GLP-1 medications help joint pain and inflammatory arthritis
PS-IPW analysis showed no significant differences in BP outcomes or target achievement rates according to the preceding treatment
